In the adult
stomach (top), ’residual embryonic cells’ (green) are sequestered near the
esophagus by mature epithelial cells (pink). Inflammatory damage caused by GERD
(middle) disrupts this epithelial layer, and creates opportunities for a REC
population to spread — forming a potentially precancerous growth (bottom).
Primitive cell
populations retained from early embryonic development could provide the seeds
for precancerous
growths
Heartburn makes for an uncomfortable post-meal
experience, but can also herald more serious health concerns. Indeed, gastroesophageal
reflux disease (GERD) is a causative factor underlying Barrett’s metaplasia, a
condition associated with changes in the epithelial cells lining the esophagus
that can ultimately lead to esophageal carcinoma.
Esophageal carcinoma incidence has increased over
five-fold in the Western world since 1970, but little is known about its
etiology. “The fact that the five-year survival rate has not appreciably
changed during this time is demoralizing and suggests that surgery, radiation
and chemotherapy have not made a dent in our ability to manage this disease,”
says Frank McKeon at the A*STAR Genome Institute of Singapore. However,
patients may draw hope from new findings obtained by a team led by McKeon, and
Wa Xian of the A*STAR Institute of Medical Biology, using a
genetically-modified mouse strain that models Barrett’s metaplasia1.
These animals, lacking a protein called p63, exhibited
metaplasia in the epithelial cells where the esophagus meets the stomach. The
team, led by McKeon and Xian, observed striking changes in gene expression in
this subset of cells, with a strong correlation in the genes that were
differentially expressed among p63-deficient mouse tissues and samples from
human patients with Barrett’s metaplasia.
The researchers identified two marker proteins that
allowed them to visualize the cells that contribute to metaplasia during
embryonic development. In wild-type mice, these cells initially line the
stomach, but subsequently get displaced by the expansion of a population of p63-expressing
epithelial cells. In p63-deficient animals, however, these embryonic epithelial
cells linger and turn metaplastic.
Importantly, wild-type mice still retain a population of
these cells, dubbed ‘residual embryonic cells’ (RECs), in the stomach region
adjacent to the esophagus, and analysis of human tissues revealed a similar
population of RECs at the gastroesophageal junction. The researchers
hypothesize that these cells represent an ‘opportunistic’ population that is
normally prevented from proliferating by fully mature ‘indigenous’ epithelia.
By inducing damage to this mature epithelium, GERD may thus allow RECs to
proliferate unchecked (see image).
The findings suggest that Barrett’s esophagus does not
arise from the typical activating mutations seen in early precursors of
cancers, but rather exploits damage to the esophagus in order to expand and
grow. This ‘rogue cell’ model could potentially underlie other cancers, and the
researchers are now examining whether it is possible to avert esophageal
carcinoma by selectively eliminating RECs. “We are identifying unique cell
surface targets for targeted therapy to destroy these cells,” say Xian.
The A*STAR-affiliated researchers contributing to this
research are from the Genome
Institute of Singapore and the Institute of Medical Biology
References
- Wang,
X. et al. Residual embryonic cells as precursors of a
Barrett’s-like metaplasia. Cell 145, 1023–1035
(2012). | article
No comments:
Post a Comment